Skip to content

Fulgent Genetics, Inc. FLGT Ratios & Valuation

Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Profitability
Gross margin38.7%-0.1pp40.6%+2.7pp41.2%+5.0pp40%+0.9pp38.8%+1.3pp
Operating margin-33.1%-8.5pp-28.2%-2.2pp-22.5%+52.7pp-24%+41.9pp-24.6%+42.4pp
Net margin-23%-9.1pp-18.8%-3.7pp-13.6%+45.8pp-16.8%+39.4pp-13.9%+43.8pp
Returns
Return on equity-6.8%-3.2pp-5.4%-1.6pp-3.8%+10.0pp-4.5%+9.1pp-3.6%+10.2pp
Return on invested capital-10.1%-3.4pp-8.5%-1.5pp-6.8%+11.6pp-6.9%+9.8pp-6.7%+10.1pp
Efficiency
Asset turnover0.3×0.0×0.3×0.0×0.3×0.0×0.2×0.0×0.2×0.0×
Liquidity
Current ratio5.3×-1.0×6.5×+1.6×+2.6×+0.7×6.3×+1.2×
Leverage
Debt-to-equity0.0×0.0×0.0×0.0×0.0×
Per Share
Book value per share$34.00-7.0%$36.13-3.6%$36.62-2.2%$36.56-2.8%$36.56-3.7%
Valuation
Market capitalization$552.11M-7.1%$812.07M+43.7%$691.76M+5.1%$594.26M+1.2%$521.63M-19.3%
Price / sales1.7×-0.3×2.5×+0.5×2.2×-0.2×-0.1×1.8×-0.5×
Price / book0.5×0.0×0.7×+0.2×0.6×0.0×0.5×0.0×0.5×-0.1×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Fulgent Genetics, Inc.'s profit margins?
Fulgent Genetics, Inc. (FLGT) runs a 38.7% gross margin and a -33.1% operating margin, with a -23.0% net margin.
Where do Fulgent Genetics, Inc.'s ratios come from?
Every ratio is computed from Fulgent Genetics, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.